Robert W. Baird Boosts Mettler-Toledo International (NYSE:MTD) Price Target to $1,230.00

Key Points

• Robert W. Baird has increased Mettler-Toledo International's price target from $1,210.00 to $1,230.00, indicating a potential upside of 2.60% from the stock's previous close.
• Other analysts have mixed ratings on the stock; UBS upgraded it to "buy" but lowered its target to $1,350.00, while Citigroup set a price target of $1,400.00.
• Mettler-Toledo International reported earnings of $10.09 per share, surpassing expectations, with a revenue increase of 3.9% compared to the prior year.

Mettler-Toledo International (NYSE:MTD - Get Free Report) had its target price increased by research analysts at Robert W. Baird from $1,210.00 to $1,230.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a "neutral" rating on the medical instruments supplier's stock. Robert W. Baird's target price would indicate a potential upside of 2.60% from the stock's previous close.

Several other research analysts have also weighed in on MTD. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their target price for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Citigroup raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target for the company in a research report on Monday, April 7th. Wells Fargo & Company boosted their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday, May 5th. Wall Street Zen cut Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Finally, Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and reduced their price target for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $1,300.50.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,198.77 on Monday. Mettler-Toledo International has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01. The stock's 50-day moving average is $1,193.61 and its two-hundred day moving average is $1,192.54. The firm has a market cap of $24.91 billion, a P/E ratio of 30.36, a PEG ratio of 3.64 and a beta of 1.34.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%. The company had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same period in the prior year, the firm posted $9.65 EPS. The business's revenue was up 3.9% compared to the same quarter last year. As a group, research analysts expect that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the transaction, the director directly owned 120 shares of the company's stock, valued at $139,191.60. The trade was a 89.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.77% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in shares of Mettler-Toledo International by 1.2% in the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock valued at $3,003,485,000 after buying an additional 30,535 shares during the period. Alliancebernstein L.P. lifted its stake in shares of Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock valued at $837,653,000 after buying an additional 126,147 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Mettler-Toledo International by 5.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock valued at $568,032,000 after buying an additional 25,272 shares during the period. T. Rowe Price Investment Management Inc. lifted its stake in shares of Mettler-Toledo International by 11.9% in the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock valued at $479,673,000 after buying an additional 43,082 shares during the period. Finally, GAMMA Investing LLC lifted its stake in shares of Mettler-Toledo International by 131,246.3% in the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock valued at $456,018,000 after buying an additional 385,864 shares during the period. 95.07% of the stock is owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.